KalVista Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
CEOBenjamin L. Palleiko
CEOBenjamin L. Palleiko
Employees270
Employees270
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2004
Founded2004
Employees270
Employees270
KALV Key Statistics
Market cap692.74M
Market cap692.74M
Price-Earnings ratio-3.57
Price-Earnings ratio-3.57
Dividend yield—
Dividend yield—
Average volume1.69M
Average volume1.69M
High today$14.49
High today$14.49
Low today$13.68
Low today$13.68
Open price$14.18
Open price$14.18
Volume1.52M
Volume1.52M
52 Week high$17.28
52 Week high$17.28
52 Week low$7.30
52 Week low$7.30
Stock Snapshot
The current KalVista Pharmaceuticals(KALV) stock price is $13.71, with a market capitalization of 692.74M. The stock trades at a price-to-earnings (P/E) ratio of -3.57.
On 2025-11-19, KalVista Pharmaceuticals(KALV) stock moved within a range of $13.68 to $14.49. With shares now at $13.71, the stock is trading +0.2% above its intraday low and -5.4% below the session's peak.
Trading activity shows a volume of 1.52M, compared to an average daily volume of 1.69M.
The stock's 52-week range extends from a low of $7.30 to a high of $17.28.
The stock's 52-week range extends from a low of $7.30 to a high of $17.28.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own KALV. This list is generated using Robinhood data, and it’s not a recommendation.